The OPTI Study in Spain Looks at the History Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Inhaled Steroids.
The OPTI Study in Spain Looks at the History Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Inhaled Steroids.
This non-Interventional, descriptive, cross-sectional cohort and multicentre study will be
 conducted with COPD patients attended at Spanish Primary Care offices.
Inclusion Criteria:

 1. Written informed consent prior to participation

 2. Female and male patient ≥ 40 years of age

 3. Chronic Obstructive Pulmonary Disease (COPD) diagnosis more than 2 years before the
 study visit

 4. Previously confirmed Chronic Obstructive Pulmonary Disease (COPD) diagnosis
 (post-bronchodilator FEV1/FVC ratio <70%)

 5. Clinical data available 2 years before the study visit

 6. Ability to complete CAT - COPD Assessment Test

 Exclusion Criteria:

 1. Current participation in any clinical trial involving a drug or device

 2. A moderate or severe exacerbation (requiring oral corticosteroid, antibiotics or
 hospitalisation) during the study visit or within 4 weeks before the study visit